Compare KZIA & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KZIA | TKLF |
|---|---|---|
| Founded | 1994 | 2006 |
| Country | Australia | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 15.6M |
| IPO Year | 1999 | 2022 |
| Metric | KZIA | TKLF |
|---|---|---|
| Price | $13.05 | $2.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 15.2K |
| Earning Date | 12-26-2025 | 12-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.57 |
| Revenue | $1,199,108.00 | ★ $210,119,238.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.71 |
| Revenue Growth | N/A | ★ 7.38 |
| 52 Week Low | $2.86 | $2.43 |
| 52 Week High | $25.40 | $4.32 |
| Indicator | KZIA | TKLF |
|---|---|---|
| Relative Strength Index (RSI) | 67.12 | 35.11 |
| Support Level | $7.68 | $2.43 |
| Resistance Level | $11.13 | $2.76 |
| Average True Range (ATR) | 2.06 | 0.23 |
| MACD | 0.52 | -0.00 |
| Stochastic Oscillator | 69.83 | 23.68 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.